TMBIM6 and non-small cell lung carcinoma: To evaluate whether TMBIM6 was required for the effect of STRIP2-IGF2BP3 on NSCLC progression, we knocked down TMBIM6 expression in PC9 cells, and then overexpressed STRIP2 or IGF2BP3 in these cells.